论文信息 - MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer. - 字舞流文

MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancer.

N. Rioux-Leclercq | F. Beuvon | A. Lièvre | A. Lespagnol | F. Bibeau | L. Doucet | R. Coriat | S. Corre | M. Galibert | S. Guyétant | C. Bossard | J. Bennouna | J. Edeline | P. Artru | M. de Tayrac | T. Lecomte | R. Desgrippes | D. Grasset | D. Coupez | K. Bouhier‐Leporrier | R. Chautard | Anthony Perrot | F. Leclair | Emeric Boisteau | P. Poureau | Lucile Bauguion | P. Chalabreysse | S. Martin-Lannerée | Hélène Lhostis | Sébastien Corre